Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment

Patient Preference for Treatment of Moderate-To-Severe Psoriasis in Japan

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05065762

Acronym

DCE

Enrollment

232

Registered

2021-10-04

Start date

2021-10-01

Completion date

2022-02-07

Last updated

2022-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Keywords

Psoriasis, Japan, BMS-986165, Observational study, Moderate-to-severe PsO, DCE (discrete choice experiment), Preferences

Brief summary

The purpose of this observational study is to identify and weight the treatment attributes from the moderate-to-severe Psoriasis (PsO) patients' perspective in Japan.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosis of moderate-to-severe Psoriasis (PsO) by physician (phase 1) or self-reported (phase 2) * Currently taking systemic psoriasis treatment * Japanese resident aged 20 years and older

Exclusion criteria

* Unable or unwilling to provide informed consent * Diagnosis of guttate, inverse, pustular, erythrodermic, or drug-induced psoriasis

Design outcomes

Primary

Measure	Time frame
Distribution of socio-demographic characteristics of PsO participants in Phase 1: Level of income	At Baseline
Psoriasis (PsO) patient preferences of moderate-to-severe systemic treatment atrribute	Within 60 minutes of survey/interview
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 1: Sex	At Baseline
Distribution of socio-demographic characteristics of PsO participants in Phase 1: Age	At Baseline
Distribution of clinical characteristics of PsO participants in Phase 1: Time since PsO diagnosis	At Baseline
Distribution of clinical characteristics of PsO participants in Phase 1: Severity of PsO	At Baseline
Distribution of clinical characteristics of PsO participants in Phase 1: Current treatments for PsO	At Baseline
Distribution of clinical characteristics of PsO participants in Phase 1: Time on current PsO treatment	At Baseline
Distribution of socio-demographic characteristics of PsO participants in Phase 1: Residence	At Baseline
Distribution of socio-demographic characteristics of PsO participants in Phase 1: Employment status	At Baseline
Distribution of socio-demographic characteristics of PsO participants in Phase 1: Education	At Baseline
Distribution of clinical characteristics of PsO participants in Phase 1: Total number of previous treatments	At Baseline
Distribution of clinical characteristics of PsO participants in Phase 1: Previous treatments for PsO	At Baseline
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Sex	At Baseline
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Age	At Baseline
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Height	At Baseline
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Weight	At Baseline
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Residence	At Baseline
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Employment status	At Baseline
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Type of occupation	At Baseline
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Education	At Baseline
Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Time since PsO diagnosis	At Baseline
Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Self-reported severity	At Baseline
Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Current treatments for PsO	At Baseline
Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Time on current PsO treatment	At Baseline
Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Previous treatments for PsO	At Baseline
Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Comorbid conditions of interest	At Baseline
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Level of income	At Baseline

Countries

United States

Outcome results